Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Kubanda Cryotherapy
AddedFeb 18, 2024
UpdatedJun 18, 2026
Kubanda Cryotherapy

Kubanda Cryotherapy

Angel

Kubanda Cryotherapy: Non-surgical, minimally invasive treatment for pet ailments.

HQ
Baltimore, MD, US
Founded
2018
Overview
Compare
Fundraising
Employees

Kubanda Cryotherapy provides minimally invasive, non-surgical treatments for pets, focusing on addressing lumps, bumps, and cancers. Their mission is to offer effective and less traumatic medical solutions for pet ailments, enhancing the quality of life for animals and peace of mind for pet owners.

Kubanda Cryotherapy has made significant strides in veterinary medicine by introducing innovative cryotherapy techniques. Their impact is evident in the improved health outcomes for numerous pets, positioning them as a leader in non-surgical veterinary treatments.

Kubanda Cryotherapy - Similar Companies

CryoMedix logo

CryoMedix

cryomedix.com

Curelab Veterinary logo

Curelab Veterinary

Focused Cryo logo

Focused Cryo

Gulf States Cryotherapy logo

Gulf States Cryotherapy

Kuddly logo

Kuddly

MBF Therapeutics logo

MBF Therapeutics

Cryothermic Systems logo

Cryothermic Systems

Cryosa logo

Cryosa

cryosa.com

KwikVet logo

KwikVet

kwikvet.com

VetDC logo

VetDC

Dr.Tail logo

Dr.Tail

drtail.us

PepiPets logo

PepiPets

pepipets.com

Caerus logo

Caerus

caeruscorp.com

Bond Vet logo

Bond Vet

bondvet.com

Veterinary Care logo

Veterinary Care

Kubanda Cryotherapy - Quick Facts

Who are Kubanda Cryotherapy's competitors?

Companies similar to Kubanda Cryotherapy include CryoMedix, Curelab Veterinary, Focused Cryo and Gulf States Cryotherapy.

When was Kubanda Cryotherapy founded?

Kubanda Cryotherapy was founded in 2018.

Where is Kubanda Cryotherapy's headquarters located?

Kubanda Cryotherapy's headquarters is located in Baltimore, MD, US.

When was Kubanda Cryotherapy's last funding round?

Kubanda Cryotherapy's most recent funding round was for $5k (USD) in August 2023.

How much has Kubanda Cryotherapy raised to-date?

As of Aug 23, 2023, Kubanda Cryotherapy has raised a total of $185k (USD).

How many employees does Kubanda Cryotherapy have?

Kubanda Cryotherapy has 5 employees as of Feb 5, 2024.

Kubanda Cryotherapy - Classification

Industry
  • Professional Service Companies
Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Transactional
Customer
  • Consumers
Main Product
  • Pet Care
  • Veterinary
Tags
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 9 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 330000Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies